Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Muenchhoff

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Medical Microbiology and Immunology|January 21, 2022
Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variantsChristopher Dächert, Maximilian Muenchhoff, Alexander Graf, et al.
Frontiers in Immunology|July 24, 2019
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected ChildrenJulia Roider, J Zachary Porterfield, Paul Ogongo, et al.
Microbiology Spectrum|August 8, 2023
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concernGabriel Diem, Stefanie Dichtl, Viktoria Zaderer, et al.
Infection|January 30, 2021
Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injuryStéphanie Bieber, Angelina Kraechan, Johannes C Hellmuth, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 5, 2025
[Point-of-care tests for sexually transmitted infections-what is the current status?]Viviane Bremer, Heinrich Scheiblauer, Maximilian Muenchhoff, et al.
Antiviral Research|March 25, 2023
Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammationStefanie Dichtl, Gabriel Diem, Michael Jäger, et al.
Thrombosis Journal|May 2, 2023
How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scoresJakob Vielhauer, Christopher Benesch, Anna Pernpruner, et al.
Journal of Virology|November 10, 2021
Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIVVinicius A Vieira, Emily Adland, Nicholas E Grayson, et al.
Journal of Virology|July 11, 2014
Impact of HLA selection pressure on HIV fitness at a population level in Mexico and BarbadosClaudia I Juarez-Molina, Rebecca Payne, Maribel Soto-Nava, et al.
Frontiers in Immunology|November 2, 2023
Omicron subvariants illustrate reduced respiratory tissue penetration, cell damage and inflammatory responses in human airway epitheliaViktoria Zaderer, Hussam Abd El Halim, Anna-Lena Wyremblewsky, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Medical Microbiology and Immunology|January 21, 2022
Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variantsChristopher Dächert, Maximilian Muenchhoff, Alexander Graf, et al.
Frontiers in Immunology|July 24, 2019
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected ChildrenJulia Roider, J Zachary Porterfield, Paul Ogongo, et al.
Microbiology Spectrum|August 8, 2023
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concernGabriel Diem, Stefanie Dichtl, Viktoria Zaderer, et al.
Infection|January 30, 2021
Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injuryStéphanie Bieber, Angelina Kraechan, Johannes C Hellmuth, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 5, 2025
[Point-of-care tests for sexually transmitted infections-what is the current status?]Viviane Bremer, Heinrich Scheiblauer, Maximilian Muenchhoff, et al.
Antiviral Research|March 25, 2023
Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammationStefanie Dichtl, Gabriel Diem, Michael Jäger, et al.
Thrombosis Journal|May 2, 2023
How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scoresJakob Vielhauer, Christopher Benesch, Anna Pernpruner, et al.
Journal of Virology|November 10, 2021
Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIVVinicius A Vieira, Emily Adland, Nicholas E Grayson, et al.
Journal of Virology|July 11, 2014
Impact of HLA selection pressure on HIV fitness at a population level in Mexico and BarbadosClaudia I Juarez-Molina, Rebecca Payne, Maribel Soto-Nava, et al.
Frontiers in Immunology|November 2, 2023
Omicron subvariants illustrate reduced respiratory tissue penetration, cell damage and inflammatory responses in human airway epitheliaViktoria Zaderer, Hussam Abd El Halim, Anna-Lena Wyremblewsky, et al.
Pageof 9